Skip to main content

54 150 Pill - white capsule/oblong, 14mm

Pill with imprint 54 150 is White, Capsule/Oblong and has been identified as Flecainide Acetate 150 mg. It is supplied by Hikma Pharmaceuticals PLC.

Flecainide is used in the treatment of Atrial Fibrillation; Supraventricular Tachycardia; Atrial Flutter; Wolff-Parkinson-White Syndrome; Paroxysmal Supraventricular Tachycardia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Flecainide 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 54 150

Flecainide acetate 150 mg 54 150
Flecainide acetate 150 mg 54 150
Flecainide acetate 150 mg 54 150 Front
Flecainide acetate 150 mg 54 150 Back

Flecainide Acetate

Imprint
54 150
Strength
150 mg
Color
White
Size
14.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Group I antiarrhythmics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Hikma Pharmaceuticals PLC
Inactive Ingredients
magnesium stearate, microcrystalline cellulose, croscarmellose sodium, corn starch

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00054-0012 Roxane Laboratories, Inc.
54868-5586 (Discontinued) Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Related images for "54 150"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.